Ardelyx Inc
SWB:41X
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Ardelyx Inc
SWB:41X
|
US |
|
S
|
Simply Good Foods Co
NASDAQ:SMPL
|
US |
|
Gossamer Bio Inc
NASDAQ:GOSS
|
US |
|
S
|
Sonos Inc
SWB:8SO
|
US |
|
MP Materials Corp
NYSE:MP
|
US |
Intrinsic Value
Is 41X undervalued or overvalued?
See the intrinsic value estimate for 
Ardelyx Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
41X looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with 41X’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Ardelyx Does
Ardelyx is a biopharmaceutical company focused on medicines for gastrointestinal and kidney-related conditions. Its main products are prescription drugs that help treat problems like constipation from certain causes and help control phosphate levels in people with chronic kidney disease. The company does not sell consumer goods; it develops and commercializes specialized therapies for doctors to prescribe.
- Headquarters
- United States of America US
- Employees
- 489
- IPO date
- Jun 19, 2014
Revenue & Expenses Breakdown
Ardelyx Inc
Earnings Waterfall
Ardelyx Inc
The intrinsic value for Ardelyx Inc (41X) under the Base Case is hidden EUR.
Compared with the current market price of 4.205 EUR, the stock appears hidden.